<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04908033</url>
  </required_header>
  <id_info>
    <org_study_id>EK-VP1421012</org_study_id>
    <nct_id>NCT04908033</nct_id>
  </id_info>
  <brief_title>Ultra-high-frequency ECG for Prediction of Left Ventricular Remodeling</brief_title>
  <official_title>Ultra-high-frequency ECG for Prediction of Adverse Left Ventricular Remodeling in Permanent Right Ventricular Pacing</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Faculty Hospital Kralovske Vinohrady</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>St. Anne's University Hospital Brno, Czech Republic</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Regional Hospital Liberec</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Faculty Hospital Kralovske Vinohrady</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main goal of the project is to prove that ultra-high-frequency ECG (UHF-ECG) can be used&#xD;
      as a diagnostic tool that allows the prediction of patients susceptible to the negative&#xD;
      effect of right ventricular myocardial pacing. The prediction will be based on the assessment&#xD;
      of electrical dyssynchrony and local depolarization durations of left ventricular&#xD;
      depolarization emerging during right ventricular pacing. If proved to be valid in left&#xD;
      ventricular negative remodeling prediction, UHF-ECG-derived parameters of ventricular&#xD;
      dyssynchrony could be used as markers allowing a lead placement optimization during an&#xD;
      implant procedure. This information can help the operator to identify patients with the&#xD;
      urgent need for physiological pacing (HB or LBBp) and patients in which a right ventricular&#xD;
      myocardial pacing is sufficient and will not lead to the development of the negative left&#xD;
      ventricular remodeling.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 1, 2021</start_date>
  <completion_date type="Anticipated">May 1, 2025</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2024</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>negative remodeling prediction</measure>
    <time_frame>1 year from randomization</time_frame>
    <description>5% drop in the left ventricular ejection fraction will be predicted by the duration of UHF-ECG electrical dyssynchrony parameter&#xD;
5% drop in the left ventricular ejection fraction will be predicted by the duration of UHF-ECG left ventricular lateral wall delay parameter&#xD;
5% drop in the left ventricular ejection fraction will be predicted by the duration of UHF-ECG V6d parameter&#xD;
10% drop in the left ventricular ejection fraction will be predicted by the duration of UHF-ECG left ventricular lateral wall delay parameter&#xD;
10% drop in the left ventricular ejection fraction will be predicted by the duration of UHF-ECG V6d parameter</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>RV myocardial to physiological pacing comparison</measure>
    <time_frame>2 years from randomization</time_frame>
    <description>left ventricular ejection fraction comparison between low risk right ventricular myocardial to physiological pacing group</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>UHF-ECG prediction of clinical outcome</measure>
    <time_frame>3 years from randomization</time_frame>
    <description>occurence of death, myocardial infarction, worsening heart failure or upgrade to resynchronization therapy will be predicted by the duration of UHF-ECG electrical dyssynchrony, and/or left ventricular lateral wall delay and/or V6d parameter</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">360</enrollment>
  <condition>RV Pacing</condition>
  <condition>Negative Remodeling</condition>
  <condition>Dyssynchrony</condition>
  <condition>UHF-ECG</condition>
  <condition>Physiological Pacing</condition>
  <arm_group>
    <arm_group_label>myocardial pacing group</arm_group_label>
    <description>patients with the pacing lead placed into the right ventricle to obtain myocardial capture</description>
  </arm_group>
  <arm_group>
    <arm_group_label>physiological pacing group</arm_group_label>
    <description>patients with the pacing lead placed into the His bundle or left bundle branch area</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>pacemaker implantation</intervention_name>
    <description>pacemaker implantation</description>
    <arm_group_label>myocardial pacing group</arm_group_label>
    <arm_group_label>physiological pacing group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        360 patients with an indication for permanent pacing due to permanent conduction disease&#xD;
        of/below the AV node&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. expectation of permanent right ventricular pacing with atrio-ventricular delay set to&#xD;
             150/180 ms (130/160 resp.) for sensed/paced atrial events during a follow-up,&#xD;
&#xD;
          2. a good quality of images during echocardiography,&#xD;
&#xD;
          3. willingness to attend clinical check-ups in the implanting center for at least two&#xD;
             years.&#xD;
&#xD;
          4. life expectancy of at least 2 years&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. planned cardiac surgery or transcatheter aortic valve implantation&#xD;
&#xD;
          2. hypertrophic cardiomyopathy&#xD;
&#xD;
          3. an indication for implantable cardioverter-defibrillator, biventricular implantable&#xD;
             cardioverter-defibrillator, or biventricular pacemaker&#xD;
&#xD;
          4. active myocarditis&#xD;
&#xD;
          5. cardiac surgery or coronary revascularization in the last ten days&#xD;
&#xD;
          6. persistent/permanent atrial fibrillation during randomization&#xD;
&#xD;
          7. severe aortic stenosis&#xD;
&#xD;
          8. mitral valvular disease with an indication to intervention.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>karol curila</last_name>
    <phone>00420777869171</phone>
    <email>curilakarol@seznam.cz</email>
  </overall_contact>
  <location>
    <facility>
      <name>Karol Curila</name>
      <address>
        <city>Praha 10</city>
        <zip>10000</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>karol curila, MD, Phd,MSc</last_name>
      <phone>00420777869171</phone>
      <email>curilakarol@seznam.cz</email>
    </contact>
  </location>
  <location_countries>
    <country>Czechia</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 15, 2021</study_first_submitted>
  <study_first_submitted_qc>May 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 1, 2021</study_first_posted>
  <last_update_submitted>May 25, 2021</last_update_submitted>
  <last_update_submitted_qc>May 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Faculty Hospital Kralovske Vinohrady</investigator_affiliation>
    <investigator_full_name>Karol Curila</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <keyword>myocardial pacing</keyword>
  <keyword>physiological pacing</keyword>
  <keyword>negative remodeling</keyword>
  <keyword>dyssynchrony</keyword>
  <keyword>ultra-high-frequency ECG</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ventricular Remodeling</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

